Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Link to related guidelines are provided separately. (See "Society guideline links: Myelodysplastic syndromes".)
International
●National Marrow Donor Program (NMDP) and Center for International Blood and Marrow Transplant Research (CIBMTR): Guidelines on the selection of unrelated donors and cord blood units for hematopoietic cell transplantation (2019)
●Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients, update (2017)
●Pediatric Blood and Marrow Transplant Consortium (PBMTC): Consensus statement on the late effects screening guidelines after hematopoietic cell transplantation for inherited bone marrow failure syndromes (2017)
●Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome (2011)
Canada
●Choosing Wisely Canada: Don't routinely give immunoglobulin replacement to adult hematopoietic cell transplantation recipients in the absence of recurrent infections regardless of the IgG level (updated 2020)
●Choosing Wisely Canada: Don't routinely use peripheral blood stem cells for patients with aplastic anemia when a suitable bone marrow donor is available due to a higher risk of graft-versus-host disease (updated 2020)
●Cancer Care Ontario (CCO): Consensus pathology recommendations for complex malignant hematology (2016)
●CCO: Stem cell transplantation in myelodysplastic syndromes and acute myeloid leukemia (2012)
United States
●American Society for Transplantation and Cellular Therapy (ASTCT): An expert panel opinion on bone health management after hematopoietic cell transplantation (2020)
●Fanconi Anemia Research Fund (FARF): Fanconi anemia clinical care guidelines, 5th edition (2020)
●American Society of Clinical Oncology (ASCO)/American Society of Hematology (ASH): Clinical practice guideline for the management of cancer-associated anemia with erythropoiesis-stimulating agents, update (2019)
●Choosing Wisely: Don't routinely administer granulocyte colony stimulating factor (G-CSF) for empiric treatment of pediatric patients with asymptomatic autoimmune neutropenia in the absence of recurrent or severe bacterial and/or fungal infections (2019)
●Choosing Wisely: Don't transfuse platelets in an asymptomatic (i.e., non-bleeding) pediatric patient (e.g. aplastic anemia, leukemia, etc.), with a platelet count > 10,000/mcL unless other signs and/or symptoms for bleeding are present, or if the patient is to undergo an invasive procedure (2019)
●European Society for Blood and Marrow Transplantation (EBMT), American Society for Blood and Marrow Transplantation (ASBMT), Eastern Mediterranean Blood and Marrow Transplantation (EMBMT), and Physical Therapy Association for Graft Versus Host Disease (PTAGVHD): Role of physical therapy before and after hematopoietic stem cell transplantation − White paper report (2019)
●National Marrow Donor Program (NMDP) and Center for International Blood and Marrow Transplant Research (CIBMTR): Guidelines on the selection of unrelated donors and cord blood units for hematopoietic cell transplantation (2019)
●ASCO and Infectious Diseases Society of America (IDSA): Clinical practice guideline for outpatient management of fever and neutropenia in adults treated for malignancy, update (2018)
●Choosing Wisely: Do not perform peripheral blood flow cytometry to screen for hematological malignancy in the settings of mature neutrophilia, basophilia, erythrocytosis, thrombocytosis, isolated anemia, or isolated thrombocytopenia (2018)
●College of American Pathologists (CAP) and ASH: Guideline on the initial diagnostic workup of acute leukemia (2017)
●Choosing Wisely: Do not perform fluorescence in situ hybridization (FISH) for myelodysplastic syndrome (MDS)-related abnormalities on bone marrow samples obtained for cytopenias when an adequate conventional karyotype is obtained (2016)
●ASBMT: Guidelines on indications for autologous and allogeneic hematopoietic cell transplantation (2015)
●Dyskeratosis Congenita Outreach (DCO): Dyskeratosis congenita and telomere biology disorders – Diagnosis and management guidelines (2015)
●ASBMT: Recommended screening and preventative practices for long-term survivors after hematopoietic cell transplantation (2012)
Europe
●European Society for Medical Oncology (ESMO): Myelodysplastic syndromes – Clinical practice guidelines for diagnosis, treatment and follow-up (2020)
●European Society for Blood and Marrow Transplantation (EBMT): A position paper on anti-complement treatment for paroxysmal nocturnal hemoglobinuria – Time for proximal complement inhibition? (2019)
●EBMT, American Society for Blood and Marrow Transplantation (ASBMT), Eastern Mediterranean Blood and Marrow Transplantation (EMBMT), and Physical Therapy Association for Graft Versus Host Disease (PTAGVHD): Role of physical therapy before and after hematopoietic stem cell transplantation − White paper report (2019)
●EBMT: Consensus guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in haploidentical hematopoietic cell transplantation (2018)
●EBMT: Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes (2015)
United Kingdom
●British Society for Haematology (BSH): Paediatric amendment to adult BSH guidelines for aplastic anaemia (2018)
•BSH: Guidelines for the diagnosis and management of adult aplastic anaemia (2016)
●Choosing Wisely UK: Royal College of Pathologists – Don't transfuse red cells for iron deficiency anaemia without haemodynamic instability (2018)
●National Institute for Health and Care Excellence (NICE): Guideline on blood transfusion (2015)
●NICE: Clinical guideline on neutropenic sepsis – Prevention and management in people with cancer (2012)
Japan
●[In Japanese] Japanese Society of Hematology (JSH): Hematopoietic tumor clinical practice guidelines (2018)
